Correlação da massa e porcentagem de gordura com a idade na distrofia muscular de Duchenne

Caromano, Fátima Aparecida; Tanaka, Clarice; João, Sílvia Maria Amado; Kamisaki, Ana Patrícia; Yano, Kelly Cristina; Ide, Maiza Ritomy

doi:10.1590/s0103-51502010000200006

Cited by 5 publications

(2 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As in the study by Rose et al 1 , anthropometric data were obtained, and the values of height and weight of the evaluated patients were similar to the findings of other authors 14,17 . Based on the normative data of Rose et al 1 , the weight and length of the lower limbs of patients 1 and 2 were lower, and of patient 3 were similar.…”

Section: Discussionsupporting

confidence: 86%

“…In this study, the increase in energy expenditure with age is consistent with the accumulation of body fat and the loss of lean mass, characteristic aspects of the progression of the DMD 17 . Still, only 3 patients showed higher energy expenditure, when compared to the normative data from Rose et al 1 , which seems to be justified due to a higher percentage of fat than in other evaluated patients.…”

Section: Discussionsupporting

confidence: 78%

See 1 more Smart Citation

Gait energy expenditure in children with Duchenne muscular dystrophy: case study

Souza¹,

Ferreira²,

Baptista³

et al. 2014

Fisioter. Pesqui.

View full text Add to dashboard Cite

| This case study aimed to verify the model of Rose et al. 1 as a feasible to assess energy expenditure in gait of children with Duchenne muscular dystrophy (DMD). Three DMD patients aged 6, 7 and 8 years old participated of this study. It was obtained weight, height, leg length measurement (LLM), resting and gait heart rate (HR) held on as 55-meter oval circuit performed during a two-minute test at each speed. Energy expenditure was calculated using the HR. It was performed a descriptive analysis (average) and these were compared, individually, to normative data. The average gait speed of these three patients was similar to the normative data for slow speed and lower considering comfortable and fast speed. The energy expenditure to slow speed of the patients 2 and 3 was similar to the normality, and lowest for patient 1; at comfortable speed, the energy expenditure obtained for all patients was similar; at fast speed, the patients 1 and 2 presented similar to normal values, but the patient 3 presented higher energy expenditure. It was concluded that the energy expenditure evaluation using HR was easily executed in the clinical practice and it can help therapeutic choices. For patient 3, an aerobic training could be indicated and for the others, they could keep the routine assessments.

show abstract

Section: Discussionsupporting

confidence: 86%

Section: Discussionsupporting

confidence: 78%

Gait energy expenditure in children with Duchenne muscular dystrophy: case study

Souza¹,

Ferreira²,

Baptista³

et al. 2014

Fisioter. Pesqui.

View full text Add to dashboard Cite

show abstract

When age matters: boys with Duchenne muscular dystrophy have growth delay and a fat mass accumulation, as they get older

Cunha

Grilo

Costa

et al. 2021

RSD

View full text Add to dashboard Cite

Anthropometry and body composition evaluation in boys with Duchenne muscular dystrophy (DMD) are challenging, but crucial methods to evaluate the nutritional status, and better anthropometric reference values and body composition predictive equations are needed for this population. Based on these aspects, this study aimed to investigate the hypothesis that changes in anthropometric parameters and body composition of boys with DMD occur according to age. A cross-sectional study with 49 individuals diagnosed with DMD at the neurological outpatient facility at the Onofre Lopes University Hospital in Natal, Brazil, was performed between September 2016 and March 2019. These individuals underwent anthropometric and body composition evaluation. According to age, the participants were divided into four groups: G1 (2.6 - 8.2y), G2 (8.5 - 10.8y), G3 (11.0 - 14.0y), and G4 (15.9 - 23.0y). The parameters weight-for-age (W/A) (p=0.025), tricipital skinfold (TSF) (p=0.027), adductor pollicis muscle (p=0.041), and corrected arm muscle area (cAMA) (p=0.005) were different among the groups. Regarding anthropometric parameters, was prevalence in the categories of appropriate W/A and a height-for-age (H/A), and eutrophy for body mass index-for-age (BMI/A). For the TSF, there was a higher frequency of severe malnutrition or obesity. The cAMA indicated severe malnutrition in most individuals. As for %FM, high adiposity was more frequent, increasing over age groups (G1 to G4). The boys with DMD presented different patterns of anthropometric and body composition parameters. An increase of fat mass and a decrease of lean mass with age/disease progression were observed.

show abstract

Tecnologia Assistiva na Distrofia Muscular de Duchenne

Carbonero

Zago²,

Campos³

2001

Rev Neurocienc

View full text Add to dashboard Cite

RESUMOA Distrofia Muscular de Duchenne (DMD) é a doença neuromuscular mais frequente em crianças, com incidência de 1 para cada 3.500 recém nascidos do sexo masculino. Trata-se de uma patologia progressiva, causadora de limitação motora, perda da deambulação e óbito por volta da segunda década de vida. A Tecnologia Assistiva (TA) corresponde a uma ampla gama de serviços e equipamentos aplicados para minimizar os déficits funcionais de pessoas com deficiência. Objetivo. O presente estudo teve como objetivo verificar os benefícios da TA em portadores da DMD. Método. Tratou-se de um trabalho de revisão de literatura. Foram utilizados livros e artigos publicados na base de dados lilacs, scielo e pubmed, nas línguas portuguesa e inglesa. Resultados. Foram selecionados 31 artigos científicos, 2 dissertações, 1 manual e 06 livros. Conclusão. Os estudos analisados mostraram a importância da prescrição e inclusão da TA no tratamento da DMD, pois tais recursos podem prevenir encurtamentos musculares, prorrogar o tempo da marcha e, consequentemente, adiar o confinamento à cadeira de rodas e óbito precoce por complicações respiratórias. ABSTRACTDuchenne Muscular Dystrophy (DMD) is the most frequent neuromuscular disease in children, with an incidence of 1 in every 3,500 newborn males. It is a progressive disorder that causes motor limitation, loss of ambulation capability and death around the second decade of life. The Assistive Technology (AT) represents a broad range of services and equipments used to minimize the functional deficits of persons with disabilities. Objective. The purpose of this study was to verify the benefits of AT in patients with DMD. Method. This was a literature review and researches performed on databases such as virtual lilacs, scielo and pubmed, in both Portuguese and English languages. Results. We selected 31 papers, 2 essays, 1 manual and 6 books. Conclusion. The results showed the importance of the inclusion and prescription of AT in the treatment of DMD as it prevents muscular shortening, extends the ambulation time deferring confinement to a wheelchair and early death due to respiratory complications.

show abstract

Correlação da massa e porcentagem de gordura com a idade na distrofia muscular de Duchenne

Cited by 5 publications

References 20 publications

Gait energy expenditure in children with Duchenne muscular dystrophy: case study

Gait energy expenditure in children with Duchenne muscular dystrophy: case study

When age matters: boys with Duchenne muscular dystrophy have growth delay and a fat mass accumulation, as they get older

Tecnologia Assistiva na Distrofia Muscular de Duchenne

Contact Info

Product

Resources

About